Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Petrylak

Showing results (1-10 of 226) with videos related to

Pageof 23
Sort By:
Seminars in Urologic Oncology|August 29, 2002
Chemotherapy for androgen-independent prostate cancerDaniel P Petrylak
Oncology (Williston Park, N.Y.)|July 2, 2011
Evolving therapeutic paradigms for advanced prostate cancer: what's needed to make optimal use of the new treatmentsDaniel P Petrylak
The Journal of Urology|May 20, 2015
Should the Urologist Treat Castration Resistant Prostate Cancer? NoDaniel P Petrylak
The Canadian Journal of Urology|April 30, 2014
Practical guide to the use of chemotherapy in castration resistant prostate cancerDaniel P Petrylak
Reviews in Urology|October 6, 2006
The treatment of hormone-refractory prostate cancer: docetaxel and beyondDaniel P Petrylak
Current Urology Reports|May 3, 2011
Current clinical trials in castrate-resistant prostate cancerDaniel P Petrylak
Cancer Investigation|August 29, 2002
Salvage therapy for platinum-refractory urothelial cancer: designing new clinical trialsDaniel P Petrylak
Current Oncology Reports|April 2, 2003
Early chemohormonal therapy in prostate cancer: preliminary data and randomized trialsDaniel P Petrylak
Cancer Journal (Sudbury, Mass.)|October 18, 2016
From the Guest Editor: The Spectrum of Treatment of Metastatic Prostate Cancer: Present and FutureDaniel P Petrylak
Clinical Genitourinary Cancer|June 22, 2017
Immunotherapy: The Wave of the Future in Bladder Cancer?Daniel P Petrylak
Pageof 23

Showing results (1-10 of 226) with videos related to

Sort By:
Pageof 23
Seminars in Urologic Oncology|August 29, 2002
Chemotherapy for androgen-independent prostate cancerDaniel P Petrylak
Oncology (Williston Park, N.Y.)|July 2, 2011
Evolving therapeutic paradigms for advanced prostate cancer: what's needed to make optimal use of the new treatmentsDaniel P Petrylak
The Journal of Urology|May 20, 2015
Should the Urologist Treat Castration Resistant Prostate Cancer? NoDaniel P Petrylak
The Canadian Journal of Urology|April 30, 2014
Practical guide to the use of chemotherapy in castration resistant prostate cancerDaniel P Petrylak
Reviews in Urology|October 6, 2006
The treatment of hormone-refractory prostate cancer: docetaxel and beyondDaniel P Petrylak
Current Urology Reports|May 3, 2011
Current clinical trials in castrate-resistant prostate cancerDaniel P Petrylak
Cancer Investigation|August 29, 2002
Salvage therapy for platinum-refractory urothelial cancer: designing new clinical trialsDaniel P Petrylak
Current Oncology Reports|April 2, 2003
Early chemohormonal therapy in prostate cancer: preliminary data and randomized trialsDaniel P Petrylak
Cancer Journal (Sudbury, Mass.)|October 18, 2016
From the Guest Editor: The Spectrum of Treatment of Metastatic Prostate Cancer: Present and FutureDaniel P Petrylak
Clinical Genitourinary Cancer|June 22, 2017
Immunotherapy: The Wave of the Future in Bladder Cancer?Daniel P Petrylak
Pageof 23